KEYNOTE SPEAKERS
Thomas W. Abrams, RPh, MBA
Director, Office of Prescription Drug Promotion, US Food and Drug Administration, Silver Spring, MD
Susan Dentzer
President and Chief Executive Officer, NEHI (The Network for Excellence in Health Innovation), Analyst on Health Policy, The NewsHour, Former Editor, Health Affairs, Washington, DC
Mary E. Riordan, Esq.
Senior Counsel, Office of Counsel to the Inspector General, Office of Inspector General, US Department of Health and Human Services, Washington, DC
James Sheehan, JD
Chief, Charities Bureau, Attorney General of New York, Former Chief Integrity Officer, New York City Human Resources Administration, Former, NY Medicaid Inspector General, Former AUSA, US Attorney’s Office, Eastern District of Pennsylvania, New York, NY
Jim Stansel, JD
Executive Vice President, General Counsel and Corporate Secretary, PhRMA, Former Acting General Counsel, US Department of Health and Human Services, Washington, DC
KEYNOTE DOJ CIVIL AND CRIMINAL DIVISIONS ROUNDTABLE
Colin M. Huntley, JD
Assistant Director, Fraud Section, Civil Division, US Department of Justice, Washington, DC
Pablo Quiñones, JD
Chief, Strategy, Policy and Training Unit, Fraud Section, Criminal Division, US Department of Justice, Former Assistant United States Attorney in the Criminal Division, US Attorney’s Office for the Southern District of New York, Washington, DC
Gejaa T. Gobena, JD
Partner, Hogan Lovells, Former Deputy Chief, Fraud Section, Criminal Division, Former Trial Attorney, Civil Division, Fraud Section, US Department of Justice, Washington, DC (Moderator)
KEYNOTE DOJ, SEC AND FBI FCPA ENFORCEMENT ROUNDTABLE
Charles Cain, Esq.
Deputy Chief, FCPA Unit, US Securities and Exchange Commission, Washington, DC
Tarek Helou, Esq.
Assistant Chief, FCPA Unit, Fraud Section, Criminal Division, US Department of Justice, Washington, DC
Darryl Wegner, JD
Unit Chief, International Corruption Unit, FBI, Washington, DC
Gary F. Giampetruzzi, Esq.
Partner, Paul Hastings, Former Vice President and Assistant General Counsel, Head of Government Investigations, Pfizer Inc., New York, NY (Moderator)
KEYNOTE AUSA ROUNDTABLE
Jacob T. Elberg
Chief, Health Care and Government Fraud Unit, United States Attorney’s Office, District of New Jersey, US Department of Justice, Newark, NJ
Jason Mehta, JD
Assistant US Attorney, United States Attorney’s Office Middle District of Florida, US Department of Justice, Jacksonville, FL
Gregg Shapiro, JD
Assistant US Attorney, US Attorney’s Office, District of Massachusetts, US Department of Justice, Boston, MA
John T. Bentivoglio, Esq.
Partner, Skadden Arps LLP, Former Special Counsel for Healthcare Fraud, and Chief Privacy Officer, US Department of Justice, Washington, DC (Moderator)
CO CHAIRS
Timothy Ayers, JD, MPH
Vice President, Chief Compliance Officer, Horizon Pharma plc, Chicago, IL
Matthew D’Ambrosio, JD, MBA
Senior Vice President, Chief Compliance and Ethics Officer, Sunovion Pharmaceuticals Inc., Chair, Pharmaceutical Compliance Forum, Marlborough, MA
Sujata T. Dayal, JD
Vice President, Health Care Compliance & Privacy, Pharmaceuticals Group, Johnson & Johnson, Titusville, NJ
Jeffrey Kawalek, MBA
Senior Director, Ethics & Compliance, North America, Ipsen Biopharmaceuticals, Inc., New York, NY
Jennifer McGee, JD
Vice President and Chief Compliance Officer, Otsuka America Pharmaceutical, Inc., Rockville, MD
Margaret Sparks, JD
Associate Vice President, North America Ethics and Business Integrity, Sanofi, US, Bridgewater, NJ
FEATURED FACULTY
Sergio Alegre, JD
Vice President, Global Compliance, Osmotica Pharmaceutical Corp., Former Executive Director Compliance, Pacira Pharmaceuticals, Inc., New York, NY
Thomas W. Beimers, Esq.
Partner, Hogan Lovells, Former Senior Counsel for Administrative and Civil Remedies, Office of the Inspector General, Department of Health and Human Services, Minneapolis, MN
Andy Bender, MS, MBA
President and Founder, Polaris, New York, NY
Katherine Buckley, MBA
Principal, Pharmaceutical and Life Sciences Advisory Practice, PwC, Philadelphia, PA
Terra Buckley
Head of US Compliance, Helsinn, Former Director, Ethics & Compliance, North America, Ipsen, Former Associate Director, Compliance, Aptalis Pharma, Iselin, NJ
Jennifer Chillas, JD
Senior Corporate Counsel, Bristol-Myers Squibb, Princeton Pike, NJ
Kellie B. Combs, JD
Partner, Ropes & Gray, Washington, DC
David Cromley, JD
Associate Vice President, Merck, Philadelphia, PA
Jill Dailey, MBA, JD
Vice President and Chief Compliance Officer, Incyte, Former Assistant General Counsel and Asia Pacific Compliance Lead, Pfizer, Former Head of US Ethics and Compliance, Novartis, New York, NY
Michelle Drozd, ScM
Deputy Vice President, Policy and Research, Pharmaceutical Research & Manufacturers of America (PhRMA), Washington, DC
Margaret K. Feltz, MA, JD
Vice President, Ethics & Compliance, Purdue Pharma LP, Former Member, PCF Executive Committee, Stamford, CT
Virginia “Ginny” A. Gibson, Esq.
Partner, Hogan Lovells LLP, Former Executive Assistant U.S. Attorney, Eastern District of Pennsylvania, US Department of Justice, Philadelphia, PA
Darren R. Jones, CIA
Managing Partner, Polaris Management Partners, New York, NY
Anup Kharode, MBA
Principal, Pharmaceutical & Life Sciences R&D Advisory Services, PwC, Philadelphia, PA
Keith M. Korenchuk, JD, MPH
Partner, Arnold & Porter LLP, Washington, DC
Daniel A. Kracov, Esq.
Partner and Head, FDA and Healthcare Practice, Arnold & Porter, Washington, DC
Jonathan Levy, JD
Corporate Compliance Lead, Spark Therapeutics, Former Associate Director of Compliance and Ethics, US Pharmaceuticals, Bristol-Myers Squibb, Philadelphia, PA
Michael K. Loucks, JD
Partner, Skadden Arps LLP; Former Acting United States Attorney, District of Massachusetts, United States Department of Justice, Washington, DC
Kathleen Meriwether, JD
Principal, Fraud Investigation & Dispute Services, Ernst & Young, Former Assistant United States Attorney, Eastern District of Pennsylvania, US Department of Justice, Philadelphia, PA
Michael A. Morse, JD
Partner, Pietragallo, Gordon, Alfano, Bosick & Raspanti, Former Assistant District Attorney, Philadelphia District Attorney’s Office, Philadelphia PA
Meghan Naas, MA
Senior Finance Manager, Compliance TESARO, Inc., Waltham, MA
Amy Pawloski
Global Lead, Compliance Risk Mitigation and Monitoring Strategy, Bristol-Myers Squibb, Philadelphia, PA
Paul J. Peterson, CPA, CIA, CFE, CFF
Senior Manager, Forensic Advisory Services, Grant Thornton, Alexandria, VA
Arjun Rajaratnam, JD, MS
Chief Compliance Officer, Smith & Nephew, Former Compliance Officer, US Pharmaceuticals, GlaxoSmithKline, Former Member, PCF Executive Committee, Raleigh, NC
David Ralston, JD, MPH
Senior Director, Associate General Counsel, Business Conduct, Gilead Sciences, Former Section Head, Abbott Laboratories, Former Senior Legal Director, Schering Plough, Foster City, CA
Kelly N. “Nikki” Reeves, MPA, JD
Partner, King & Spalding LLP, Washington, DC
Jennifer Sanfilippo, JD
Vice President, Commercial Integrity Counsel, The Medicines Company, New York, NY
Sue Seferian, JD
Health Care Compliance Officer, Johnson & Johnson, Titusville, NJ
Brian Sharkey, JD
Porzio, Bromberg & Newman, PC, Morristown, NJ
Michelle Shwery, MSc, MBA
Senior Director, Ethics and Compliance, Eli Lilly and Company, Indianapolis, IN
Paul Silver
Principal, Regulatory & Compliance Life Sciences Leader, Deloitte Advisory, Deloitte, Atlanta, GA
Julie Ritchie Wagner, JD
Assistant General Counsel, PhRMA, Former Senior Counsel, Office of Counsel to the Inspector General, US Department of Health and Human Services, Washington, DC
Donna White, CCEP
Vice President, Contracts & Compliance, Chiesi USA, Inc., Former Sr. Director, Contracts and Compliance, Cornerstone Therapeutics, Cary, NC
Seth B. Whitelaw, JD, LLM, SJD
President and Chief Executive Officer, Whitelaw Compliance Group, LLC, Editor, Life Science Compliance Update, Former Interim Chief Compliance Officer, Misonix, Inc., West Chester, PA
2017-2018 GLOBAL PHARMA COMPLIANCE CONGRESSES
ELEVENTH INTERNATIONAL PHARMACEUTICAL AND MEDICAL DEVICE COMPLIANCE CONGRESS
Sponsored by International Society of Healthcare Compliance Professionals (ETHICS)
Cosponsored by Pharmaceutical Compliance Forum (PCF)
May 15 – 17, 2017
Lisbon Marriott Hotel
Lisbon, Portugal
www.InternationalPharmaCongress.com
SEVENTH ASIA PACIFIC PHARMACEUTICAL AND MEDICAL DEVICE COMPLIANCE CONGRESS
Sponsored by Asia Pacific Healthcare Industry Compliance Team
Cosponsored by International Society of Healthcare Ethics and Compliance Professionals (ETHICS) and Pharmaceutical Compliance Forum (PCF)
September 13 – 15, 2017
InterContinental Shanghai, Shanghai, China
www.AsianPharmaCongress.com
EIGHTEENTH ANNUAL PHARMACEUTICAL AND MEDICAL DEVICE COMPLIANCE CONGRESS
A Hybrid Conference and Internet Event
Sponsored by Pharmaceutical Compliance Forum (PCF)
November 6 – 8, 2017
Mandarin Oriental
Washington, DC
www.PharmaCongress.com
INDIAN PHARMACEUTICAL AND MEDICAL DEVICE COMPLIANCE CONGRESS
International Society of Health-
care Compliance Professionals (ETHICS)
Cosponsored by International Society of Healthcare Compliance Professionals (ETHICS) and Pharmaceutical Compliance Forum (PCF)
Spring 2018
Mumbai, India
Coming Soon
PAST GLOBAL PHARMA COMPLIANCE CONGRESSES
2007 – Brussels
2008 – Paris
2009 – Rome
2010 – Berlin
2011 – Istanbul
2011 – Singapore
2012 – Budapest
2012 – Shanghai
2012 – São Paulo
2013 – Madrid
2013 – Kuala Lumpur
2014 – Dubai
2014 – Mexico City
2014 – Shanghai
2015 – Manila
2016 – Warsaw